SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Pastimes : Investment Chat Board Lawsuits -- Ignore unavailable to you. Want to Upgrade?


To: Arcane Lore who wrote (1887)8/21/2001 5:40:04 PM
From: Arcane Lore  Read Replies (1) | Respond to of 12465
 
Tuesday August 21, 1:49 pm Eastern Time

Press Release

SOURCE: Med-Design Corporation

Med-Design Responds to Spurious Chat Room Rumors and Attacks

VENTURA, Calif., Aug. 21 /PRNewswire/ -- The Med-Design Corporation (Nasdaq: MEDC - news), a leader in the design and development of safety-engineered needle products for medical use, today was forced to respond to libelous and blatantly false statements posted on an Internet chat room.

While it is not policy of the Company to respond to anonymous chat room rumors, these inaccurate and libelous statements have resulted in various investor inquires, which have distracted management. In addition, these blatantly false statements may have negatively impacted the performance of Med-Design stock. As a result, and to ensure compliance with SEC Fair Disclosure regulations, management is compelled to issue a public statement addressing these wholly inaccurate claims.

James Donegan, Chairman and CEO of The Med-Design Corporation, and the Company's largest individual shareholder, is not, never has, nor will he in the future collar or otherwise sell any derivative/hedged position on his holdings in The Med-Design Corporation. None of Mr. Donegan's stock holdings are or ever were hedged or collared by Bank of America or any other financial institution. Furthermore, Mr. Donegan has not sold any Med-Design stock since November 2000 when he exercised a warrant. The Company has authorized its outside attorneys to attempt to identify the author of said libelous statements and institute appropriate legal action.

Finally, given the current legislative environment and the overwhelming support from health care practitioners, Med-Design believes that safety is here to stay. The Company also believes that the marketplace for quality, user-friendly safety-engineered needle devices is large enough to allow healthy competition. Med-Design stands by its position that Retractable Technologies' recent 8-K attack is inaccurate; however, the company does not intend to engage in a public debate with any competitor who attacks Med-Design in an attempt to distract the public from focusing on the competitor's inadequacies.

Forward Looking Statements

This release may contain forward-looking statements, which are included in accordance with the ``safe harbor'' provisions of the Private Securities Litigation Reform Act of 1995 and accordingly, the cautionary statements contained in Med-Design's Annual Report on form 10-K for the year ended December 31, 2000 (See Item 1 - Business, and Item 7 - Management's Discussion and Analysis of Financial Conditions and Results of Operations, and elsewhere), and other filings with the Securities and Exchange Commission are incorporated herein by reference. Such forward-looking statements may involve known and unknown risks, uncertainties and other factors that may cause the Company's actual results and performance in future periods to be materially different from any future results or performance suggested by the forward- looking statements in this release. Such forward-looking statements speak only as of the date of this release. The Company expressly disclaims any obligation to update or revise any forward-looking statements found herein to reflect any changes in Company expectations of results or any change in events.

For more information on Med-Design Corporation you may access the Med- Design Corporation web site at med-design.com.

CONTACT: Michael Simpson, Chief Operating Officer of Med-Design, +1-805-339-0375, or Eric Van Zanten of Tierney Communications, +1-215-790-4358, for Med-Design.

SOURCE: Med-Design Corporation

biz.yahoo.com